Blog

No more nudes in Playboy magazine, centerfold's future at risk: report

(Reuters) – Now readers of Playboy, the glossy men’s magazine known for its nude fold-outs, can honestly say they are buying the magazine for its articles. Playboy will no longer publish nude photographs of women, the New York Times reported on Monday in an article quoting Scott Flanders, the company’s chief executive. Founder and editor-in-chief Hugh Hefner, 89, who in his trademark silk pajamas has embodied the Playboy lifestyle, agreed

U.S. prescription opioid misuse and deaths increase

By Kathryn Doyle (Reuters Health) – The proportion of people reporting use of prescription opioids for reasons other than medical necessity fell between 2003 and 2013, but use disorders and overdose deaths increased, according to a new study. “The results underscore the importance of addressing the prescription opioid crisis,” said lead author Dr. Beth Han of the Substance Abuse and Mental Health Services Administration (SAMHSA) in Rockville, Maryland. High-intensity opioid

Michigan library acquires papers of assisted-suicide advocate Dr. Kevorkian

A University of Michigan library said on Tuesday that it has acquired the papers of Dr. Jack Kevorkian, an assisted-suicide advocate known nationally as “Dr. Death” for helping more than 100 people end their lives. The papers, which were donated by Kevorkian’s niece Ava Janus, comprise materials spanning 1911 to 2014 and are open to the public, according to the university’s Bentley Historical Library. A pathologist, Kevorkian, who died at

J&J says its diabetes drug should have same survival edge as Lilly's

Dominic Caruso, J&J’s chief financial officer, on Tuesday gave his optimistic view of the new drug class, called SGLT2 inhibitors, during a conference call with industry analysts to discuss the company’s third-quarter earnings. Lilly last month said that a three-year study showed Jardiance slashed deaths by 32 percent in patients with type 2 diabetes at risk of heart attack and stroke – a finding that could make it a mainstay